市场继续缩量，全天走出小幅冲高回落的普跌行情。 1、行情 题材方面，医药板块继续大涨，永安药业3连板，海森药业、海翔药业2连板，众生药业、多瑞医药（20CM）、海辰药业（20CM）、新天地 （20CM）先后涨停，科源制药、华海药业、常山药业等大涨，三生国健早盘一度跌超10%，午后迎来反弹最终跌幅收窄至3.56%； 2、核电 今日开盘，核电、核聚变板块集体反弹。 尚纬股份一字（2板），融发核电、哈焊华通（20CM）、雪人股份开盘快速涨停； 核聚变开盘走强，王子新材6天5板，尚纬股份2板，融发核电、哈焊华通（20CM）、雪人股份、中洲特材（20CM）纷纷涨停，常辅股份、国光 电气、合锻智能、中核科技、兰石重装等盘中均有大涨表现； 量子科技盘中局部发力，格尔软件涨停，禾信仪器、科大国创、国盾量子、神州信息、吉大正元、复旦复华等或大幅高开或盘中大涨，但整体呈 现冲高回落走势； 无人驾驶整体也冲高回落，德迈仕20CM涨停（T字），动力新科（炸）、万安科技（炸）涨停，东土科技、天迈科技、合众思壮、美湖股份、 天准科技、经纬恒润、浙江世宝等早盘均集体大涨； 汽车整车、零部件板块局部发力，赛力斯、汉马科技（炸）涨停，隆盛科技 ...

Group 1 - China Communication Technology Co., Ltd. won a total of 11 important rail transit projects with a total bid amount of approximately 3.789 billion yuan, accounting for 11.67% of the company's audited revenue for 2024 [1] - New Chai Co., Ltd. plans to use no more than 500 million yuan of idle funds to purchase low-risk financial products to improve fund efficiency [2] - Qingshan Paper Industry's controlling shareholder intends to restructure and inject assets into Fujian Provincial Industrial Holding Group [3] Group 2 - BWS hired Liu Xiaodan as Senior Vice President, effective immediately [4] - Huakang Clean won a bid for a purification project at the Tengzhou Medical and Health Center, with a bid price of 60.2394 million yuan [6] - Silver Dragon Co., Ltd. announced that several executives plan to reduce their holdings by a total of no more than 550,000 shares due to personal financial needs [8] Group 3 - Intercontinental Oil & Gas plans to invest 848 million USD in the South Basra Integrated Project in Iraq, holding a 67% stake [13] - Huatai Dain's subsidiary received a drug registration certificate for sodium valproate oral solution, used for treating epilepsy [14] - Hainan Mining's 20,000-ton battery-grade lithium hydroxide project has achieved full-process connectivity and produced qualified products [29] Group 4 - Roman Co., Ltd.'s subsidiary won a significant overseas project in Saudi Arabia with a bid amount of approximately 200 million yuan [30] - Measurement Co., Ltd. completed a capital reduction for its subsidiary, optimizing resource allocation [31] - Guodian Nanzi plans to increase capital by 45 million yuan for its wholly-owned subsidiary to meet market expansion needs [32] Group 5 - Eighty Billion Space plans to repurchase shares with a total amount not less than 50 million yuan and not exceeding 100 million yuan [33] - Tianyin Electromechanical's director plans to reduce holdings of no more than 0.25% of the company's shares [34] - Hailier's subsidiary passed environmental protection acceptance for its agricultural chemical preparation project [35] Group 6 - Kelong Pharmaceutical's subsidiary will present innovative drug research results at the ASCO annual meeting [36] - Zhonghong Medical's subsidiary received medical device registration certificates for enteral nutrition pumps and injection pumps [37] - Luyou Pharmaceutical received a drug registration certificate for amlodipine besylate tablets, used for hypertension [39]

Group 1 - The core viewpoint of the news is the introduction of policies aimed at enhancing the financial support for technological innovation in China, which is expected to address the financial challenges faced by major technological tasks and small and medium-sized tech enterprises [2] - The policies will simultaneously target both the supply and demand sides to promote a "dual approach" between technology and finance, ultimately establishing a long-term investment mechanism for financial support of technological innovation [2] - The capital market's response to these policies indicates that the construction of a technology finance mechanism aims to fundamentally resolve existing pain points in technology development, thereby increasing the attractiveness of sci-tech stocks to long-term capital [2] Group 2 - As of May 22, 2025, the Shanghai Stock Exchange Sci-Tech Innovation Board Composite Index (000680) has shown a slight increase of 0.24%, with notable gains from constituent stocks such as Lanjian Intelligent (688557) up 15.06% and Aikesaibo (688719) up 9.03% [1] - The Huaxia Sci-Tech Innovation Index ETF (589000) closely tracks the performance of the Sci-Tech Innovation Board Composite Index, reflecting the overall performance of eligible listed companies on the board, including dividend income [2][3] - The top ten weighted stocks in the Sci-Tech Innovation Board Composite Index account for 23.41% of the index, indicating a concentration of investment in these key companies [3]

Group 1 - Quantum technology sector experienced significant gains on May 23, with stocks like Geer Software hitting the limit up, and Keda Guochuang rising over 10% [1] - On May 22, IonQ's new CEO expressed ambitions for the company to become the Nvidia of quantum computing, leading to a surge in US quantum computing stocks, with IonQ up nearly 37%, D-Wave Quantum up 24%, and Rigetti Computing up 26% [8] - Nvidia's CEO predicted that future supercomputers will incorporate quantum acceleration, highlighting the growing importance of quantum computing in high-performance computing [8] Group 2 - The geopolitical landscape has increased the demand for digital security, making quantum information development a key focus for national policy support, which is expected to create opportunities in the quantum technology sector [9] - Quantum computing is emerging as a strategic area in global technological competition, with chemical research projected to contribute 60% of quantum computing demand in the medium term [9] - The global quantum technology industry is expected to exceed $8 billion in 2024, with a compound annual growth rate of 76.27% from 2024 to 2030, and the quantum computing market alone projected to reach $807.75 billion by 2035 [9]

Group 1 - Hongchuang Holdings plans to acquire 100% equity of Shandong Hongtuo Industrial for 63.518 billion yuan, transforming from a single aluminum deep processing business to a full industry chain including electrolytic aluminum, alumina, and aluminum deep processing [3] - LIZHU Group intends to acquire 64.81% of Vietnam's Imexpharm Corporation for approximately 1.587 billion yuan, enhancing its presence in the pharmaceutical sector [4][5] - China Power Construction reported a new contract amount of 386.49 billion yuan from January to April, a year-on-year decrease of 4.9% [7] Group 2 - Wanhua Chemical announced a scheduled maintenance for its production facilities, including a five-month technical upgrade for its Yantai ethylene unit, which will not significantly impact operations [8] - Changhong High-Tech received a warning letter from the Ningbo Securities Regulatory Bureau for failing to disclose related party transactions in a timely manner [9] - Highgreat plans to invest 10 million yuan in Blue Core Computing, which focuses on RISC-V architecture chips [10] Group 3 - Xidi Micro plans to increase capital by 30 million USD in its wholly-owned subsidiary Hong Kong Xidi Micro to support its expanding business [12] - Bichuang Technology lost its high-tech enterprise qualification, resulting in an increase in corporate income tax rate from 15% to 25% for the years 2023 to 2025 [13] - Tonghua Dongbao intends to transfer 5.7% of its shares in Xiamen Tebao Biological Engineering for a total of 1.301 billion yuan [16] Group 4 - Tian Tie Technology signed a strategic cooperation agreement with Shenzhen Xinjie Energy to collaborate on solid-state battery lithium metal anode materials [23] - Nanjing Port disclosed that its stock trading has shown signs of market sentiment overheating, indicating potential irrational trading behavior [24] - Zhongnan Media signed a government procurement contract worth 1.009 billion yuan, ensuring stable revenue for its main business [25]

Core Points - The company held its first extraordinary shareholders' meeting on May 22, 2025, to elect the fourth board of directors and subsequently convened the first meeting of the new board to elect the chairman and appoint senior management [1][2] Group 1: Chairman Election - The board unanimously elected Mr. Zhou Zhen as the chairman of the fourth board of directors, with his term starting from the approval date of the board meeting until the end of the board's term [1] Group 2: Special Committee Election - The fourth board of directors established various special committees, with the following appointments: - Audit Committee: Chaired by Chen Ming, with members Chen Ming, Zhou Zhen, and Liu Qiliang - Nomination Committee: Chaired by Liu Qiliang, with members Liu Qiliang, Kong Yunfei, and Zhou Zhen - Compensation and Assessment Committee: Chaired by Liu Qiliang, with members Liu Qiliang, Kong Yunfei, and Zhou Zhen - Strategic Development Committee: Chaired by Zhou Zhen, with members Zhou Zhen, Xu Xiangdong, and Liu Qiliang - Independent directors hold a majority in the Audit, Nomination, and Compensation Committees, with the Audit Committee chaired by a professional accountant [2] Group 3: Senior Management Appointments - The board unanimously appointed Mr. Xu Xiangdong as the General Manager, Mr. Sun Jiande as the Chief Financial Officer, and Mr. Lu Wanli as the Secretary of the Board, with their terms starting from the approval date of the board meeting until the end of the board's term - Mr. Lu Wanli holds a qualification certificate for board secretaries issued by the Shanghai Stock Exchange and has passed the qualification filing [2][5]

Core Viewpoint - The legal opinion letter confirms the legality of the 2025 first extraordinary general meeting of shareholders of Guangzhou Hexin Instrument Co., Ltd., ensuring compliance with relevant laws and regulations [1][2][3]. Group 1: Meeting Procedures - The company provided necessary materials for the legal opinion, ensuring their authenticity and completeness [3]. - The notice for the meeting was published, detailing the date, time, location, agenda, and contact information for shareholders [4][5]. - The meeting's convening procedures were found to comply with the Company Law and Securities Law [6]. Group 2: Meeting Conduct - The meeting was held at the designated location and time as stated in the notice [6]. - The meeting utilized both on-site and online voting methods, with results being monitored and counted by designated personnel [7]. Group 3: Attendance and Voting - A total of 2 shareholders and their proxies attended the meeting, holding 20,500,186 shares, which accounted for a significant portion of the voting rights [7]. - The voting results showed overwhelming support for the proposals, with 41,145,661 shares in favor, representing 99.9897% of the votes cast [10][15]. Group 4: Conclusion - The legal opinion concludes that the meeting's procedures, attendance qualifications, and voting results are all in compliance with applicable laws and regulations, rendering the resolutions passed at the meeting as valid [23].

证券代码：688622 证券简称：禾信仪器 公告编号：2025-040 广州禾信仪器股份有限公司 关于选举董事长、董事会专门委员会委员、聘任高级管理人员 的公告 | 薪酬与考核委员会 | 刘启亮 | 刘启亮、孔云飞、周振 | | --- | --- | --- | | 战略发展委员会 | 周振 | 周振、徐向东、刘启亮 | 其中审计委员会、提名委员会、薪酬与考核委员会中独立董事均占半数以上， 并由独立董事担任召集人，且审计委员会召集人陈明先生为会计专业人士。 上述专门委员会委员简历详见公司于 2025 年 4 月 30 日刊登在上海证券交易所 网站（www.sse.com.cn）的《关于董事会换届选举的公告》（公告编号：2025-027）。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 广州禾信仪器股份有限公司（以下简称"公司"）于 2025 年 5 月 22 日召开 2025 年第一次临时股东会选举产生了第四届董事会董事。2025 年 5 月 22 日，公司召开 第四届董事会第一次会议，选举产生了董事长及董事会专门委员 ...

广州禾信仪器股份有限公司 2025年第一次临时股东会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东会召开的时间：2025 年 05 月 22 日 证券代码：688622 证券简称：禾信仪器 公告编号：2025-039 （四） 表决方式是否符合《公司法》及公司章程的规定，股东会主持情况等。 本次会议由公司董事会召集，董事长周振先生主持，以现场投票和网络投票 相结合的方式进行表决。会议的召集、召开与表决符合《公司法》《公司章程》 及公司《股东会议事规则》的规定。 （五） 公司董事、监事和董事会秘书的出席情况 二、 议案审议情况 （一） 非累积投票议案 1、 议案名称：《关于取消监事会、监事及修改<公司章程>的议案》 （二） 股东会召开的地点：广州市黄埔区新瑞路 16 号 1 楼公司大会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 15 | ...

北京市中伦（广州）律师事务所 关于广州禾信仪器股份有限公司 2025 年第一次临时股东会的 法律意见书 二〇二五年五月 北京市中伦（广州）律师事务所 关于广州禾信仪器股份有限公司 2025 年第一次临时股东会的 法律意见书 致：广州禾信仪器股份有限公司 北京市中伦（广州）律师事务所（以下简称"本所"）接受广州禾信仪器股 份有限公司（以下简称"公司"）委托，指派孙巧芬律师和胡婕律师（以下简称 "本所律师"）对公司 2025 年第一次临时股东会（以下简称"本次股东会"）的 合法性进行见证并出具法律意见。 本所及本所律师依据《中华人民共和国证券法》（以下简称"《证券法》"）、 《律师事务所从事证券法律业务管理办法》和《律师事务所证券法律业务执业规 则（试行）》等规定及本法律意见书出具日以前已经发生或者存在的事实，严格 履行了法定职责，遵循了勤勉尽责和诚实信用原则，进行了充分的核查验证，保 证本法律意见所认定的事实真实、准确、完整，所发表的结论性意见合法、准确， 不存在虚假记载、误导性陈述或者重大遗漏，并承担相应法律责任。 本法律意见书根据《中华人民共和国公司法》（以下简称"《公司法》"）、《证 券法》等现行有效的法 ...